Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders Ruyan WuJun-Xu Li Leading Article 12 November 2021 Pages: 1239 - 1248
Vitamin D Supplementation and Cognition in Adults: A Systematic Review of Randomized Controlled Trials Olivier BeauchetLiam A. Cooper-BrownGilles Allali Systematic Review 22 November 2021 Pages: 1249 - 1264
Antipsychotic-Induced Constipation: A Review of the Pathogenesis, Clinical Diagnosis, and Treatment Yue XuNousayhah AmdaneeXiangrong Zhang Review Article 24 August 2021 Pages: 1265 - 1274
The Impact of Lithium on Brain Function in Bipolar Disorder: An Updated Review of Functional Magnetic Resonance Imaging Studies Emilio BergamelliLorenzo Del FabroPaolo Brambilla Review Article Open access 12 November 2021 Pages: 1275 - 1287
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) Simona LattanziLaura CanafogliaBRIVAFIRST Group Membership Original Research Article Open access 02 September 2021 Pages: 1289 - 1301
Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials Nathaniel F. WatsonCraig W. DavisJean-Charles Schwartz Original Research Article Open access 25 November 2021 Pages: 1303 - 1315
Nusinersen: A Review in 5q Spinal Muscular Atrophy Sheridan M. Hoy Adis Drug Evaluation Open access 30 November 2021 Pages: 1317 - 1328
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) Simona LattanziLaura CanafogliaBRIVAFIRST Group Membership Correction Open access 17 November 2021 Pages: 1329 - 1331
Comment on “Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis” Johanne Pereira RibeiroMie Sedoc JørgensenOle Jakob Storebø Letter to the Editor 07 November 2021 Pages: 1333 - 1334
Authors’ Reply to Pereira Ribeiro et al.: Comment on “Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta‑Analysis” Gerald GartlehnerKaren CrottyMeera Viswanathan Letter to the Editor 07 November 2021 Pages: 1335 - 1336
